Regulation of the synthesis of plasminogen activator inhibitor type 1 (PAI-1): pathogenetic mechanism of atherosclerosis in diabetes mellitus?

被引：3

作者：

Nordt, TK

Peter, K

Kubler, W

Bode, C

机构：

来源：

FIBRINOLYSIS & PROTEOLYSIS | 1997年 / 11卷

关键词：

D O I：

10.1016/S0268-9499(97)80088-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：141 / 147

页数：7

相关论文

共 75 条

[31] DETERMINATION OF TOTAL SERUM-INSULIN (IRI) IN INSULIN-TREATED DIABETIC PATIENTS
HEDING, LG
[J]. DIABETOLOGIA, 1972, 8 (04) : 260 - &
[32] HUBER K, 1992, THROMB HAEMOSTASIS, V67, P209
[33] HUGHES HC, 1986, LAB ANIM SCI, V36, P348
[34] INSULIN THERAPY IN TYPE-2 DIABETIC SUBJECTS SUPPRESSES PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ACTIVITY AND PROINSULIN-LIKE MOLECULES INDEPENDENTLY OF GLYCEMIC CONTROL
JAIN, SK
NAGI, DK
SLAVIN, BM
LUMB, PJ
YUDKIN, JS
[J]. DIABETIC MEDICINE, 1993, 10 (01) : 27 - 32
[35] JOHNSONTIDEY RR, 1994, AM J PATHOL, V144, P952
[36] INCREASED PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND ATHEROTHROMBOSIS
JUHANVAGUE, I
ALESSI, MC
VAGUE, P
[J]. DIABETOLOGIA, 1991, 34 (07) : 457 - 462
[37] THE USE OF CULTURED HUMAN ENDOTHELIAL-CELLS AND HEPATOCYTES AS AN INVITRO MODEL SYSTEM TO STUDY MODULATION OF ENDOGENOUS FIBRINOLYSIS
KOOISTRA, T
[J]. FIBRINOLYSIS, 1990, 4 : 33 - 39
[38] KOOISTRA T, 1989, THROMB HAEMOSTASIS, V62, P123
[39] KRISHNAMURTI C, 1987, BLOOD, V69, P798
[40] LANDIN K, 1991, THROMB HAEMOSTASIS, V65, P130

← 1 2 3 4 5 6 7 8 →